Manufacturers and distributors of engineered stone countertops have knowingly marketed a product containing nanoscale crystalline silica despite warnings about its dangers, according to a Bloomberg Businessweek investigation.
The reporting centers on workers like Tyler Jordan, a former countertop fabricator who developed accelerated silicosis and kidney failure after years handling engineered stone products. His medical odyssey—dialysis, chemotherapy, kidney transplant and other interventions—illustrates a larger pattern of the industry prioritizing market dominance over worker safety.
Engineered stone contains at least 90 percent respirable crystalline silica by volume, often in nanoparticles with high surface area reactivity. The remaining 10 percent comprises resins, adhesives, dyes and heavy metals. Scientific evidence linking this composition to aggressive silicosis has accumulated for years, yet the industry continued manufacturing and selling the product across North America even as internal communications, product warnings and mounting litigation suggested decision-makers understood the risks.
The defendants named in lawsuits—Cambria, Caesarstone, Cosentino, Daltile, Arizona Tile, Architectural Surfaces Group, Surface Warehouse, Paragon Industries, Hyundai L&C and numerous distributors—represent different nodes in a fragmented supply network that obscures accountability.
Pulmonologist Jane Fazio described silicosis in stark terms: "I would wish that my patients with silicosis only had lung cancer. Lung cancer can be removed." Silicosis doesn't just kill; it degrades quality of life in ways that make even terminal diagnoses seem preferable.
Australia implemented a national ban on engineered stone manufacturing in 2024 after evidence accumulated substantially. California regulators are now moving toward restrictions on crystalline silica in engineered stone products.
The National Institute for Occupational Safety and Health has stated plainly that "the safest approach" is using products containing little to no crystalline silica. Yet manufacturers continued producing and marketing the product aggressively.
Litigation is mounting as more countertop fabricators receive diagnoses. In America, accountability sometimes works through the courts after workers are already sick, rather than through prevention or proactive regulation.
Workers fabricating countertops in shops across America continue to be exposed to the hazard. The legal consequences are multiplying as the public health crisis unfolds in real time.
